Skip to main content
. 2021 Jun 1;37(6):409–420. doi: 10.1089/aid.2021.0028

Table 4.

Summary Macaque Efficacy Data with Oral Tenofovir Alafenamide (TAF) and FTC/TAF

  Rectal challenge (rhesus macaques) Vaginal challenge (pigtail macaques)
TAF Supra therapeutic dose 13.7 mg/kg Clinical dose (1.5 mg/kg)
∼1,600 fmol/106 PBMC ∼300 fmol/106 PBMC
∼1,000 fmol/106 rectal lymphocytes ∼5 fmol/mg of vaginal tissue
No protection 58%–73% efficacy
FTC/TAF Clinical dose (1.5 mg/kg) Clinical dose (1.5 mg/kg)
100% efficacy 91%–100% efficacy

PBMC, peripheral blood mononuclear cell.